Literature DB >> 1655775

Activation of the ryanodine receptor Ca2+ release channel of sarcoplasmic reticulum by a novel scorpion venom.

H H Valdivia1, O Fuentes, R el-Hayek, J Morrissette, R Coronado.   

Abstract

We identified a peptide fraction from the venom of the scorpion Buthotus hottentota that stimulated binding of [3H]ryanodine to ryanodine receptors of skeletal and cardiac sarcoplasmic reticulum and brain microsomes in a highly specific manner. Activity was concentrated in a peptide fraction of Mr 5,000-8,000. Assuming a single active peptide in this fraction, we estimated a dissociation constant of 20-30 nM for the interaction of the peptide with the ryanodine receptor. The whole venom and the purified fraction activated skeletal ryanodine receptor Ca2+ release channels incorporated into planar lipid bilayers. The venom produced a 10-fold increase in the mean open time and induced the appearance of a long lasting subconductance state not seen in controls. Changes were reversible and could be induced by the partially purified venom fraction. This novel scorpion venom should be helpful in establishing the role of ryanodine receptors in the initiation of intracellular Ca2+ release in striated muscle and in nonmuscle cells containing functional ryanodine receptors such as neurons and secretory cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1655775

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Scorpion toxins targeted against the sarcoplasmic reticulum Ca(2+)-release channel of skeletal and cardiac muscle.

Authors:  H H Valdivia; M S Kirby; W J Lederer; R Coronado
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

2.  Characterization of a calcium-regulation domain of the skeletal-muscle ryanodine receptor.

Authors:  S M Hayek; X Zhu; M B Bhat; J Zhao; H Takeshima; H H Valdivia; J Ma
Journal:  Biochem J       Date:  2000-10-01       Impact factor: 3.857

3.  Purification and characterization of ryanotoxin, a peptide with actions similar to those of ryanodine.

Authors:  J Morrissette; M Beurg; M Sukhareva; R Coronado
Journal:  Biophys J       Date:  1996-08       Impact factor: 4.033

4.  Activation of the Ca2+ release channel of skeletal muscle sarcoplasmic reticulum by palmitoyl carnitine.

Authors:  R el-Hayek; C Valdivia; H H Valdivia; K Hogan; R Coronado
Journal:  Biophys J       Date:  1993-08       Impact factor: 4.033

5.  A new scorpion toxin (BmK-PL) stimulates Ca2+-release channel activity of the skeletal-muscle ryanodine receptor by an indirect mechanism.

Authors:  A Kuniyasu; S Kawano; Y Hirayama; Y H Ji; K Xu; M Ohkura; K Furukawa; Y Ohizumi; M Hiraoka; H Nakayama
Journal:  Biochem J       Date:  1999-04-15       Impact factor: 3.857

6.  Primary structure and properties of helothermine, a peptide toxin that blocks ryanodine receptors.

Authors:  J Morrissette; J Krätzschmar; B Haendler; R el-Hayek; J Mochca-Morales; B M Martin; J R Patel; R L Moss; W D Schleuning; R Coronado
Journal:  Biophys J       Date:  1995-06       Impact factor: 4.033

7.  Rapid adaptation of cardiac ryanodine receptors: modulation by Mg2+ and phosphorylation.

Authors:  H H Valdivia; J H Kaplan; G C Ellis-Davies; W J Lederer
Journal:  Science       Date:  1995-03-31       Impact factor: 47.728

8.  A novel structural class of K+-channel blocking toxin from the scorpion Pandinus imperator.

Authors:  T Olamendi-Portugal; F Gómez-Lagunas; G B Gurrola; L D Possani
Journal:  Biochem J       Date:  1996-05-01       Impact factor: 3.857

9.  Novel K(+)-channel-blocking toxins from the venom of the scorpion Centruroides limpidus limpidus Karsch.

Authors:  B M Martin; A N Ramirez; G B Gurrola; M Nobile; G Prestipino; L D Possani
Journal:  Biochem J       Date:  1994-11-15       Impact factor: 3.857

10.  Modulation of cardiac ryanodine receptors of swine and rabbit by a phosphorylation-dephosphorylation mechanism.

Authors:  A J Lokuta; T B Rogers; W J Lederer; H H Valdivia
Journal:  J Physiol       Date:  1995-09-15       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.